Critical role of macrophages in glucocorticoid driven vascular calcification in a mouse-model of atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 12, 2008, Pages 2158-2164

  Preusch, Michael R ^a   Rattazzi, Marcello ^b   Albrecht, Claudia ^a   Merle, Uta ^a   Tuckermann, Jan ^c   Schütz, Günther ^d   Blessing, Erwin ^a   Zoppellaro, Giacomo ^b   Pauletto, Paolo ^b   Krempien, Robert ^e   Rosenfeld, Michael E ^f   Katus, Hugo A ^a   Bea, Florian ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF PADOVA   (Italy)

^c FRITZ LIPMANN INSTITUTE   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e HELIOS KLINIKUM BERLIN BUCH   (Germany)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atherosclerosis; Glucocorticoid receptor; Inflammation; Macrophages; Vascular calcification

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALCIUM; CORTICOSTERONE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR MSX2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA SINUS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; BONE MARROW; CONTROL GROUP; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET; EXPERIMENTAL MOUSE; FEMALE; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IRRADIATION; LIPID BLOOD LEVEL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; WILD TYPE;

ANIMALS; ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; CALCINOSIS; CALCIUM; DISEASE MODELS, ANIMAL; FEMALE; GLUCOCORTICOIDS; HYPERLIPIDEMIAS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOPROTEGERIN; RANK LIGAND; RECEPTORS, GLUCOCORTICOID; RECEPTORS, LDL; RNA, MESSENGER;

EID: 57549106949     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.108.174128     Document Type: Article

References (39)

1. Aikawa E, Nahrendorf M, Sosnovik D, Lok VM, Jaffer FA, Aikawa M, Weissleder R. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation. 2007;115:377-386.
2. Aikawa E, Nahrendorf M, Figueiredo JL, Swirski FK, Shtatland T, Kohler RH, Jaffer FA, Aikawa M, Weissleder R. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation. 2007;26:2841-2850.
3. Steer JH, Kroeger KM, Abraham LJ, Joyce DA. Glucocorticoids suppress tumor necrosis factor-alpha expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-kappa B and c-Jun-activating transcription factor-2 binding sites in the promoter. J Biol Chem. 2000;275:18432-18440.
4. Berk BC, Gordon JB, Alexander RW. Pharmacologic roles of heparin and glucocorticoids to prevent restenosis after coronary angioplasty. J Am Coll Cardiol. 1991;17(6 Suppl B):111B-117B.
5. Muhlfelder TW, Niemetz J, Kang S. Glucocorticoids inhibit the generation of leukocyte procoagulant (tissue factor) activity. Blood. 1982;60:1169-1172.
6. Poon M, Gertz SD, Fallon JT, Wiegman P, Berman JW, Sarembock IJ, Taubman MB. Dexamethasone inhibits macrophage accumulation after balloon arterial injury in cholesterol fed rabbits. Atherosclerosis. 2001;155:371-380.
7. Villa AE, Guzman LA, Chen W, Golomb G, Levy RJ, Topol EJ. Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. J Clin Invest. 1994;93:1243-1249.
8. del Rincón I, O'Leary DH, Haas RW, Escalante A. Effect of glucocorticoids on the arteries in rheumatoid arthritis. Arthritis Rheum. 2004;50:3813-3822.
9. Mazziotti G, Angeli A, Bilezikian JP, Canalis E, and Giustina A. Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab. 2006;17:144-149.
10. Sher LB, Harrison JR, Adams DJ, Kream BE. Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signalling. Calc Tissue Int. 2006;79:118-125.
11. Derfoul A, Perkins GL, Hall DJ, Tuan RS. Glucocorticoids promote chondrogenic differentiation of adult human mesenchymal stem cells by enhancing expression of cartilage extracellular matrix genes. Stem Cells. 2006;24:1487-1495.
12. Kirton JP, Wilkinson FL, Canfield AE, Alexander MY. Dexamethasone downregulates calcification-inhibitor molecules and accelerates osteogenic differentiation of vascular pericytes: implications for vascular calcification. Circ Res. 2006;98:1264-1272.
13. Tintut Y, Patel J, Territo M, Saini T, Parhami F, Demer LL. Monocyte/macrophage regulation of vascular calcification in vitro. Circulation. 2002;105:650-655.
14. Tuckermann JP, Kleiman A, Moriggl R, Spanbroek R, Neumann A, Illing A, Clausen BE, Stride B, Foerster I, Habenicht AJ, Reichardt HM, Tronche F, Schmid W, Schuetz G. Macrophages and neutrophiles are the targets for immune suppression by glucocorticoids in contact allergy. J Clin Invest. 2007;5:1381-1390.
15. Merched AJ, Williams E, Chan L. Macrophage-specific p53 expression plays a crucial role in atherosclerosis development and plaque remodeling. Arterioscler Thromb Vasc Biol. 2003;23:1608-1614.
16. Plehm R, Barbosa ME, Bader M. Animal models of hypertension/blood pressure recording. Methods Mol Med. 2006;129:115-126.
17. Jono S, McKee MD, Murray CE, Shioi A, Nishizawa Y, Moti K, Morii H, Giachelli CM. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000;87:e10-e17.
18. Rattazzi M, Bennett BJ, Bea F, Kirk EA, Ricks JL, Speer M, Schwartz SM, Giachelli CM, Rosenfeld ME. Calcification of advanced atherosclerotic lesions in the innominate arteries of ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2005;7:1420-1425.
19. -/-) mice. Circulation. 2008;117:411-420.
20. Heasman SJ, Giles KM, Ward C, Rossi AG, Haslett C, Dransfield I. Glucocorticoid-mediated regulation of ganulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation. J Endocrinol. 2003;178:29-36.
21. Weinstein SP, Paquin T, Pritsker A, Haber RS. Glucocorticoid-induced insulin resistance: dexamethasone inhibits the actvation of glucose transport in rat skeletal muscle by both insulin and non-insulin-related stimuli. Diabetes. 1995;44:441-445.
22. Wang CN, McLeod RS, Yao Z, Brindley DN. Effects of dexamethasone on the synthesis, degradation, and secretion of apolipoprotein B in cultured rat hepatocytes. Arterioscler Thromb Vasc Biol. 1995;15:1481-1491.
23. Brindley DN. Role of glucocorticoids and fatty acids in the impairment of lipid metabolism observed in the metabolic syndrom. Int J Obes Relat Metab Disord. 1995;1:69-75.
24. Hoffmann R, Langenberg R, Radke P, Franke A, Blindt R, Ortlepp J, Popma JJ, Weber C, Hanrath P. Evaluation of a high-dose dexamethasone-eluting stent. Am J Cardiol. 2004;94:193-195.
25. Stone GW, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Ligon RW, Hartzler GO. A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplasty. Cathet Cardiovasc Diagn. 1989;18:227-231.
26. Sakai M, Biwa T, Matsumura T, Takemura T, Matsuda H, Anami Y, Sasahara T, Kobori S, Shichiri M. Glucocorticoid inhibits oxidized LDL-induced macrophage growth by supressing the expression of granulocyte/macrophage colony-stimulating factor. Arterioscler Thromb Vasc Biol. 1999;19:1726-1733.
27. Asai K, Funaki C, Hayashi T, Yamada K, Naito M, Kuzuya M, Yoshida F, Yoshimine N, Kuzuya F. Dexamethasone-induced suppression of aortic atherosclerosis in cholesterol-fed rabbits. Possible mechanisms. Arterioscler Thromb. 1993;13:892-899.
28. Chono S, Tauchi Y, Deguchi Y, Morimoto K. Efficient drug delivery to atherosclerotic lesions and the antiatherosclerotic effect by dexamethasone incorporated into liposomes in atherogenic mice. J Drug Target. 2005;13:267-276.
29. Mori K, Shioi A, Jono S, Nishizawa Y, Morii. Dexamethasone enhances In vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999;9:2112-2118.
30. Kondo T, Kitazawa R, Yamaguchi A, Kitazawa S. Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels. J Cell Biochem. 2008;103:335-345.
31. Udagwa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y, Shinki T, Gillespie MT, Martin TJ, Higashio K, Suda T. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology. 2000;141:3478-3484.
32. Ang ES, Zhang P, Steer JH, Tan JW, Yip K, Zheng MH, Joyce DA, Xu J. Calcium/calmodulin-dependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL). J Cell Physiol. 2007;212:787-795.
33. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998;12:1260-1268.
34. -/- mice. Arterioscler Thromb Vasc Biol. 2006;26:2117-2124.
35. Kaden J, Bickelhaupt S, Grobholz R, Haase K, Sarikoc A, Kilie R, Brueckmann M, Lang S, Zahn I, Vahl C, Hagl S, Dempfle C, Borggrefe M. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification. J Mol Cell Cardiol. 2004;36:57-66.
36. Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Boström K, Demer LL. Multilineage potential of cells from the artery wall. Circulation. 2003;108:2505-2510.
37. Shao JS, Aly ZA, Lai CF, Cheng SL, Cai J, Huang E, Behrmann A, Towler DA. Vascular Bmp Msx2 Wnt signaling and oxidative stress in arterial calcification. Ann N Y Acad Sci. 2007;1117:40-50.
38. Hofbauer LC, Brueck CC, Shanahan CM, Schoppet M, Dobnig H. Vascular calcification and osteoporosis - from clinical observation towards molecular understanding. Osteoporos Int. 2007;18:251-259.
39. Karsdal MA, Neutzsky-Wulff AV, Dziegiel MH, Christiansen C, Henriksen K. Osteoclasts secrete non-bone derived signals that induce bone formation. Biochem Biophys Res Comm. 2008;366:483-488.